Spotting
 Timeline
 Travel Tip
 Trip
 Race
 Social
 Greeting
 Poll
 Img
 PNR
 Pic
 Blog
 News
 Conf TL
 RF Club
 Convention
 Monitor
 Topic
 Followed
 Rating
 Correct
 Wrong
 Stamp
 HJ
 Vote
 Pred
 @
 FM Alert
 FM Approval
 Pvt
News Super Search
 ↓ 
×
Member:
Posting Date From:
Posting Date To:
Category:
Zone:
Language:
IR Press Release:

Search
  Go  

RailFans - we wander, but never get lost - Shaurya Kumar

Full Site Search
  Full Site Search  
 
Mon Aug 10 02:32:35 IST
Home
Trains
ΣChains
Atlas
PNR
Forum
Topics
Gallery
News
FAQ
Trips/Spottings
Login
Feedback
Advanced Search
<<prev entry    next entry>>
News Entry# 413313
Jul 07 (15:52) Registration for human trials of Indian vaccine for Coronavirus begins today (newsonair.com)
*health
0 Followers
799 views

News Entry# 413313  Blog Entry# 4663905   
  Past Edits
This is a new feature showing past edits to this News Post.
Indian COVID 19 vaccines are in the global race to end the coronavirus pandemic. Indian Council of Medical Research (ICMR) had written to 12 Medical Institutes in the country to start the first phase of Human Clinical Trials by registering volunteers. Our Correspondent has reported that a maximum number of these Institutes have begun the subject enrolment process which was slated to be initiated today. ICMR has partnered with Bharat Biotech International Limited to develop COVAXIN, whereas Zydus Cadila is working on ZyCov-D Vaccine.

Drug Controller General of India recently gave nod
...
more...
to the human trial for both COVAXIN and ZyCov-D vaccines marking the beginning of an end to the global pandemic. Indian manufacturers account for 60 percent of vaccine supplies made to UNICEF. Across the world, more than 140 candidate vaccines are under various stages of development. Indian institutions have also engaged in Research and Development for the development of vaccines in India. With the beginning of enrollment of volunteers today, the two Indian vaccine candidates will now be tested on 1,125 healthy volunteers in the two phases of trials. The vaccines will be evaluated for its safety, reactogenicity, tolerability and immunogenicity. Volunteers will be administered two intramuscular shots. The proposed age groups for the trials are 18-55 years for Phase I and 12-65 years for Phase II. Anand Chaturvedi, AIR News, Delhi.

Dr. Rakesh Mishra, Director of Centre for Cellular and Molecular Biology, Hyderabad has urged people not to lower their guards amidst the scientific progress on vaccine development. Speaking exclusively to AIR News, Dr. Misha lauded the preemptive and timely approach of the government which he said, provided the required impetus for the scientific development in the country.
Scroll to Top
Scroll to Bottom
Go to Mobile site
Important Note: This website NEVER solicits for Money or Donations. Please beware of anyone requesting/demanding money on behalf of IRI. Thanks.
Disclaimer: This website has NO affiliation with the Government-run site of Indian Railways. This site does NOT claim 100% accuracy of fast-changing Rail Information. YOU are responsible for independently confirming the validity of information through other sources.
India Rail Info Privacy Policy